Evidence map›Paper›PMID 33742417›Full record

ArticleDrug delivery and translational research2021

Correction to: A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin.

Irene Santalices, Carlos Vázquez-Vázquez, Manuel J Santander-Ortega, Victoria Lozano, Francisca Araújo, Bruno Sarmento, Neha Shrestha, Veronique Préat, Miguel Chenlo, Clara V Alvarez and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug delivery and translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Irene SantalicesCenter for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
Carlos Vázquez-VázquezDepartment of Physical Chemistry, Faculty of Chemistry, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
Manuel J Santander-OrtegaCellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.
Victoria LozanoCellular Neuroanatomy and Molecular Chemistry of Central Nervous System Group, School of Pharmacy, University of Castilla-La Mancha, 02071, Albacete, Spain.
Francisca AraújoInstituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.
Bruno SarmentoInstituto de Investigação E Inovação Em Saúde (i3S), Instituto Nacional de Engenharia Biomédica (INEB), Universidade Do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal.
Neha ShresthaAdvanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium.
Veronique PréatAdvanced Drug Delivery and Biomaterials, Université Catholique de Louvain, Louvain Drug Research Institute, 1200, Brussels, Belgium.
Miguel ChenloNeoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain.
Clara V AlvarezNeoplasia & Endocrine Differentiation Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida15782, Santiago de Compostela, Spain.
Federico BenettiECSIN-European Center for the Sustainable Impact of Nanotechnology, ECAMRICERT SRL, Padova, Italy.
Juan CuñarroCenter for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
Sulay TovarCenter for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
Dolores TorresDepartment of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.
María José AlonsoCenter for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain. mariaj.alonso@usc.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33742417
PMCPMC7987614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.